3-142558694-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001184.4(ATR):​c.1815T>C​(p.Asp605Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.381 in 1,611,750 control chromosomes in the GnomAD database, including 120,214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9172 hom., cov: 32)
Exomes 𝑓: 0.39 ( 111042 hom. )

Consequence

ATR
NM_001184.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.576

Publications

40 publications found
Variant links:
Genes affected
ATR (HGNC:882): (ATR serine/threonine kinase) The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]
ATR Gene-Disease associations (from GenCC):
  • Seckel syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
    Inheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial prostate carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-142558694-A-G is Benign according to our data. Variant chr3-142558694-A-G is described in ClinVar as Benign. ClinVar VariationId is 157966.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.576 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001184.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATR
NM_001184.4
MANE Select
c.1815T>Cp.Asp605Asp
synonymous
Exon 8 of 47NP_001175.2
ATR
NM_001354579.2
c.1623T>Cp.Asp541Asp
synonymous
Exon 7 of 46NP_001341508.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATR
ENST00000350721.9
TSL:1 MANE Select
c.1815T>Cp.Asp605Asp
synonymous
Exon 8 of 47ENSP00000343741.4
ATR
ENST00000661310.1
c.1623T>Cp.Asp541Asp
synonymous
Exon 7 of 46ENSP00000499589.1
ATR
ENST00000515149.3
TSL:3
n.*589T>C
non_coding_transcript_exon
Exon 7 of 18ENSP00000425897.3

Frequencies

GnomAD3 genomes
AF:
0.338
AC:
51293
AN:
151946
Hom.:
9167
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.553
Gnomad AMR
AF:
0.353
Gnomad ASJ
AF:
0.442
Gnomad EAS
AF:
0.354
Gnomad SAS
AF:
0.273
Gnomad FIN
AF:
0.372
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.370
GnomAD2 exomes
AF:
0.357
AC:
89555
AN:
251068
AF XY:
0.359
show subpopulations
Gnomad AFR exome
AF:
0.201
Gnomad AMR exome
AF:
0.319
Gnomad ASJ exome
AF:
0.454
Gnomad EAS exome
AF:
0.363
Gnomad FIN exome
AF:
0.383
Gnomad NFE exome
AF:
0.399
Gnomad OTH exome
AF:
0.387
GnomAD4 exome
AF:
0.386
AC:
563455
AN:
1459686
Hom.:
111042
Cov.:
36
AF XY:
0.384
AC XY:
278971
AN XY:
726228
show subpopulations
African (AFR)
AF:
0.194
AC:
6493
AN:
33438
American (AMR)
AF:
0.322
AC:
14361
AN:
44626
Ashkenazi Jewish (ASJ)
AF:
0.450
AC:
11732
AN:
26078
East Asian (EAS)
AF:
0.325
AC:
12850
AN:
39532
South Asian (SAS)
AF:
0.262
AC:
22573
AN:
86102
European-Finnish (FIN)
AF:
0.377
AC:
20121
AN:
53320
Middle Eastern (MID)
AF:
0.392
AC:
2257
AN:
5754
European-Non Finnish (NFE)
AF:
0.405
AC:
450233
AN:
1110540
Other (OTH)
AF:
0.379
AC:
22835
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
16638
33275
49913
66550
83188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13830
27660
41490
55320
69150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.337
AC:
51316
AN:
152064
Hom.:
9172
Cov.:
32
AF XY:
0.337
AC XY:
25075
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.202
AC:
8362
AN:
41488
American (AMR)
AF:
0.352
AC:
5380
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.442
AC:
1533
AN:
3468
East Asian (EAS)
AF:
0.354
AC:
1836
AN:
5184
South Asian (SAS)
AF:
0.272
AC:
1313
AN:
4830
European-Finnish (FIN)
AF:
0.372
AC:
3924
AN:
10542
Middle Eastern (MID)
AF:
0.439
AC:
129
AN:
294
European-Non Finnish (NFE)
AF:
0.405
AC:
27548
AN:
67964
Other (OTH)
AF:
0.372
AC:
787
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1707
3413
5120
6826
8533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.384
Hom.:
9188
Bravo
AF:
0.334
Asia WGS
AF:
0.322
AC:
1118
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 20, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 02, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome Benign:2
Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Seckel syndrome 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary cancer-predisposing syndrome Benign:1
Jul 10, 2025
GeneKor MSA
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.6
DANN
Benign
0.49
PhyloP100
0.58
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227929; hg19: chr3-142277536; COSMIC: COSV63386203; COSMIC: COSV63386203; API